Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325819 · ClinicalTrials.gov registry record · Phase 3
Acetaminophen Before Vaccines for Infants Study (AVIS)
A Phase 3 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 374
- Enrollment target
NCT00325819 is a Phase 3 study that has completed, run by Kaiser Permanente. The registered enrollment target is 374 participants.
The verdict
NCT00325819, a Phase 3 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 374 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether giving acetaminophen (the medicine in Tylenol) for routine infant vaccinations is helpful in preventing fever or other symptoms.
Interventions
- DRUG Acetaminophen
- OTHER placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00325819
The ClinicalTrials.gov registry entry for NCT00325819 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT00325819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00325819 about?
NCT00325819 is a clinical study titled "Acetaminophen Before Vaccines for Infants Study (AVIS)". The purpose of this study is to see whether giving acetaminophen (the medicine in Tylenol) for routine infant vaccinations is helpful in preventing fever or other symptoms.
What is the current status of trial NCT00325819?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 374 participants. The study started on 2006-05. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00325819?
The interventions under investigation include: Acetaminophen (DRUG), placebo (OTHER).
Who is sponsoring clinical trial NCT00325819?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.